Cargando…
Pharmacological effects of a vitamin K(1) 2,3-epoxide reductase (VKOR) inhibitor, 3-acetyl-5-methyltetronic acid, on cisplatin-induced fibrosis in rats
Cisplatin (CDDP) is a chemotherapeutic agent that is widely used in the treatment of lymphomas and solid malignancies. However, its clinical usage is limited by its severe side effects in the kidneys. Glomerular and tubular injuries in the kidneys commonly progress to interstitial fibrosis and, ulti...
Autores principales: | UCHIDA, Masashi, MIYOSHI, Tomoya, MIYAMOTO, Yohei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Veterinary Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627320/ https://www.ncbi.nlm.nih.gov/pubmed/28717059 http://dx.doi.org/10.1292/jvms.17-0216 |
Ejemplares similares
-
Phylogeny of the Vitamin K 2,3-Epoxide Reductase (VKOR) Family and Evolutionary Relationship to the Disulfide Bond Formation Protein B (DsbB) Family
por: Bevans, Carville G., et al.
Publicado: (2015) -
VKORC1 and VKORC1L1: Why do Vertebrates Have Two Vitamin K 2,3-Epoxide Reductases?
por: Oldenburg, Johannes, et al.
Publicado: (2015) -
Structure of a bacterial homolog of vitamin K epoxide reductase
por: Li, Weikai, et al.
Publicado: (2010) -
Vitamin K epoxide reductase regulation of androgen receptor activity
por: Tew, Ben Yi, et al.
Publicado: (2017) -
Improved Expression of Recombinant Human Factor IX by Co-expression of GGCX, VKOR and Furin
por: Liu, Jianming, et al.
Publicado: (2014)